Navigation Links
Nu Skin Scientists Identify Additional Free Radical Generator
Date:5/14/2008

d development. "If we can develop innovative ways to inhibit arNOX activity and prevent the production of free radicals in the first place, then we can address both sides of the equation -- correcting free radical damage from external sources, while at the same time preventing free radical production from internal sources."

Authors of the study are Dale Kern, senior scientist for Nu Skin Enterprises; Dr. Draelos; Dorothy Morre, PhD, professor of foods and nutrition, Purdue University; and D. James Morre, PhD, Dow distinguished professor of medicinal chemistry, Purdue University. Nu Skin has funded ENOX research by the Morres since 1999.

About arNOX

The arNOX enzyme is one in a class of newly-identified ECTO-NOX (external NADH oxidase or ENOX) proteins that are located on external cell membranes. ECTO-NOX proteins become increasingly active to generate additional metabolic energy as cell mitochondria age and produce less energy. arNOX has been identified in all cells tested, including serum and saliva and now the dermis and epidermis. Its unique property is that it generates superoxide at the cell surface that is capable of damaging adjacent cells, lipoproteins, and other structural components of the skin's extracellular matrix, such as collagen and elastin. Other NOX categories include tumor-NOX, viral-NOX and constitutive, or normal, NOX.

About IID2008

International Investigative Dermatology 2008 is the fifth joint meeting of the Society for Investigative Dermatology (SID), the European Society for Dermatological Research (ESDR) and the Japanese Society for Investigative Dermatology (JSID). IID2008 is hosted in Kyoto, Japan, May 14-17, and is the only major venue this year for the presentation of the latest information on skin biology and skin diseases. The conference program is widely based on any of the basic and clinical dermatological fields.

Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a global direct sellin
'/>"/>

SOURCE Nu Skin Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CSHL scientists are part of consortium that sequences platypus genome
2. Scientists identify key roadblock to gene expression
3. Scientists identify interacting proteins key to melanoma development, treatment
4. The American Psychiatric Associations Awards for Young Scientists Encourage Research Expertise in China
5. Scientists identify gatekeepers of breast cancer transition to invasive disease
6. Scientists at Yale provide explanation for how cancer spreads
7. Brookhaven scientists explore brains reaction to potent hallucinogen
8. Scientists Discover How Stomach Tumors Form
9. U.S. Scientists Receive Japan Prize on April 23, 2008
10. Scientists discover a mechanism that can send cells on the road to cancer
11. Scientists identify novel way to prevent cardiac fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Up Call as Lighthouse International and EHE International unveil a ... of New Yorkers will see a new warning sign in ... their vision. The sign, located at 10 Rockefeller Plaza and ... a l03-year-old leader in vision healthcare. It will be on ...
... Over 80 percent of Americans suffer from ... their skin, but their self esteem as well. Many reach ... in cosmetic products in the European Union and the desire ... are taking a hard look at their acne treatments and ...
... session in Orlando, FL will feature strategies and tools that increase ... ... Orlando, FL (Vocus) January 8, 2009 -- Facing unprecedented marketplace disruption ... consumer autonomy in health insurance selection - the retention of individual ...
... NEW ROCHELLE, N.Y., Jan. 8 Natural gas, believed to ... airborne particulate matter when burned in home appliances such as ... the December 2008 issue (Volume 25, Number 10) of ... Mary Ann Liebert, Inc. The paper ...
... and the University of Barcelona have shown that treatment ... pomace, results in a significant inhibition of cell proliferation ... is a novel natural compound and it is able ... colon-cancer cells via the intrinsic mitochondrial pathway. Scientifics suggest ...
... safety advocates to launch congressional campaign to prod all ... 40,000 deaths and $230 billion in economic losses.***Free Webcast ... Conference***WASHINGTON, Jan. 8 The following was issued by ... As state legislatures across the nation gear up for ...
Cached Medicine News:Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 3Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 2Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 3Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 4Health News:Particulate Emission from Natural Gas Burning Home Appliances Is Assessed in Environmental Engineering Science Journal 2Health News:Each State to Receive Report Card Grading Their Progress in Passing Model Traffic Safety Laws 2
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held medical ... an exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock ... system for the treatment of cancer in ... is the world,s first and only MRI-guided radiation therapy ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... with investigators worldwide to develop new treatments for ... diverse forms of cancer - Plenary ... of patients with early-stage breast cancer, - Four oral sessions to feature ... study in renal cell ...
... Hispanics/Latinos, People ... with Diabetes and Obese Individuals, PARSIPPANY, N.J., ... presented at the American Society of,Hypertension,s Twenty- Third Annual ... powerful combination drug AZOR(TM),(amlodipine and olmesartan medoxomil) safely and ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7
... The BioPlex 2200 system is ... platform that can deliver up to ... will initially include a panel of ... in development are in the areas ...
... and a FAM-labeled probe that is designed to ... gene. In addition, the B. pertussis ASR contains ... an internal control sequence. This ASR requires an ... reporter dyes such as the Cepheid SmartCycler System. ...
... The Stratus CS Analyzer, designed for Acute Care ... your laboratory and near patient setting. It's a ... or D-Dimer results from a whole blood sample ... 3 step process load sample and rotor, ...
... The CritSpin whisper quiet, compact system is ... anywhere fast, accurate and cost effective microhematocrits ... Reader, the CritSpin System offers a range ... complete cell packing - Meets NCCLS standards ...
Medicine Products: